D. Boral Capital Assists Wellgistics Health in Successful IPO

Wellgistics Health, Inc., a company focused on healthcare technology and pharmaceutical services, has announced the closure of its initial public offering (IPO) on Nasdaq. The IPO involved 888,889 ordinary shares at $4.50 each, raising gross proceeds of $4 million. These shares, trading under the ticker "WGRX," began trading on February 21, 2025.

The offering is intended to boost the company's financial flexibility and market presence. The funds will support general corporate needs, such as working capital and marketing. Craft Capital Management LLC and D. Boral Capital LLC are the underwriters, with legal support from Dykema Gossett PLLC and Sichenzia Ross Ferrance Carmel LLP.

A registration statement filed with the SEC was approved on February 14, 2025. The IPO is detailed in a prospectus available through various channels, including the SEC's website.